尿酸与心血管疾病的研究进展

doi:10.3760/cma.j.issn.1007-1245.2022.06.038

摘要/Abstract

摘要： 随着生活水平的提高，人类饮食水平逐渐改善，尿酸也逐渐升高，尿酸是嘌呤在人体分解的最终代谢产物，由于缺乏尿酸氧化酶（一种负责将尿酸转化为尿囊素的酶），人类暴露在比其他哺乳动物高出50倍的血清尿酸浓度中。最近多项研究表明，尿酸与心血管疾病有关，它们之间关系是复杂的，而且还没有完全阐明。现在阐述其二者的相关性，以期减少心血管疾病的患病率及病死率。

关键词: 尿酸, 高尿酸血症, 高血压, 心力衰竭, 冠心病, 心房颤动

Abstract: With the improvement of living standards, people's diet has improved, and uric acid also goes up gradually. Uric acid is the final metabolite of purine decomposition in vivo. Due to the lack of uric acid oxidase (an enzyme responsible for the conversion of uric acid to allantoin), human beings are exposed to 50 times of serum uric acid concentration than other mammals. Recent studies have shown that uric acid is related to cardiovascular diseases, and the relationship between them is complex and not yet clear. This review explains the correlation between uric acid and cardiovascular diseases, and hopes to reduce the prevalence and mortality of cardiovascular diseases.

Key words: Uric acid, Hyperuricemia, Hypertension, Heart failure, Coronary heart disease, Atrial fibrillation

刘振, 孙经武, 张宁, 刘婧玚, 石新烨, 董文敬. 尿酸与心血管疾病的研究进展[J]. 国际医药卫生导报, 2022, 28(6): 884-888.

Liu Zhen, Sun Jingwu, Zhang Ning, Liu Jingyang, Shi Xinye, Dong Wenjing. Research progress of uric acid and cardiovascular diseases[J]. International Medicine and Health Guidance News, 2022, 28(6): 884-888.

参考文献

[1] Waring WS, Adwani SH, Breukels O, et al. Hyperuricaemia does not impair cardiovascular function in healthy adults[J]. Heart, 2004, 90(2): 155-159. DOI: 10.1136/hrt.2003.016121.

[2] Padda J, Khalid K, Almanie AH, et al. Hyperuricemia in patients with coronary artery disease and its association with disease severity[J]. Cureus, 2021, 13(8): e17161. DOI: 10.7759/cureus.17161.

[3] Wei F, Sun N, Cai C, et al. Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study[J]. J Transl Med, 2016, 14(1): 110. DOI: 10.1186/s12967-016-0866-0.

[4] Mortada I. Hyperuricemia, type 2 diabetes mellitus, and hypertension: an emerging association[J]. Curr Hypertens Rep, 2017, 19(9): 69. DOI: 10.1007/s11906-017-0770-x.

[5] Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis[J]. Arthritis Care Res (Hoboken), 2011, 63(1): 102-110. DOI: 10.1002/acr.20344.

[6] Zhang Y, Zhang M, Yu X, et al. Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study[J]. J Transl Med, 2020, 18(1): 409. DOI: 10.1186/s12967-020-02590-8.

[7] Yang Y, Zhang X, Jin Z, et al. Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis[J]. J Thromb Thrombolysis, 2021, 52(4): 1084-1093. DOI: 10.1007/s11239-021-02453-z.

[8] Sun P, Chen M, Guo X, et al. Combined effect of hypertension and hyperuricemia on ischemic stroke in a rural Chinese population[J]. BMC Public Health, 2021, 21(1): 776. DOI: 10.1186/s12889-021-10858-x.

[9] Krishnan E. Hyperuricemia and incident heart failure[J]. Circ Heart Fail, 2009, 2(6): 556-562. DOI: 10.1161/CIRCHEARTFAILURE.108.797662.

[10] Huang H, Huang B, Li Y, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis[J]. Eur J Heart Fail, 2014, 16(1): 15-24. DOI: 10.1093/eurjhf/hft132.

[11] Sung SH, Chuang SY, Liu WL, et al. Hyperuricemia and pulse pressure are predictive of incident heart failure in an elderly population[J]. Int J Cardiol, 2020, 300: 178-183. DOI: 10.1016/j.ijcard.2019.11.001.

[12] Wu AH, Ghali JK, Neuberg GW, et al. Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure[J]. Am Heart J, 2010, 160(5): 928-933. DOI: 10.1016/j.ahj.2010.08.006.

[13] Huang WM, Hsu PF, Cheng HM, et al. Determinants and prognostic impact of hyperuricemia in hospitalization for acute heart failure[J]. Circ J, 2016, 80(2): 404-410. DOI: 10.1253/circj.CJ-15-0964.

[14] Palazzuoli A, Ruocco G, Pellegrini M, et al. Prognostic significance of hyperuricemia in patients with acute heart failure[J]. Am J Cardiol, 2016, 117(10): 1616-1621. DOI: 10.1016/j.amjcard.2016.02.039.

[15] Zhou HB, Xu TY, Liu SR, et al. Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure[J]. Nutr Metab Cardiovasc Dis, 2019 , 29(4): 351-359. DOI: 10.1016/j.numecd.2019.01.001.

[16] Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J]. Am J Cardiol, 2002, 89(1): 12-17. DOI: 10.1016/s0002-9149(01)02155-5.

[17] Zhang C, Jiang L, Xu L, et al. Implications of hyperuricemia in severe coronary artery disease[J]. Am J Cardiol, 2019, 123(4): 558-564. DOI: 10.1016/j.amjcard.2018.11.027. E

[18] Cheng Z, Zheng T, Zhang D, et al. High-level uric acid in asymptomatic hyperuricemia could be an isolated risk factor of cardio-cerebrovascular diseases: a prospective cohort study[J]. Nutr Metab Cardiovasc Dis, 2021, 31(12): 3415-3425. DOI: 10.1016/j.numecd.2021.08.043.

[19] Sun Y, Zhang H, Tian W, et al. Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study[J]. Aging Clin Exp Res, 2019, 31(12): 1783-1790. DOI: 10.1007/s40520- 019-01137-2.

[20] Duran M, Kalay N, Akpek M, et al. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome[J]. Angiology, 2012, 63(6): 448-452. DOI: 10.1177/0003319711426868.

[21] Madsen TE, Muhlestein JB, Carlquist JF, et al. Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease[J]. Am J Nephrol, 2005, 25(1): 45-49. DOI: 10.1159/000084085.

[22] Padda J, Khalid K, Almanie AH, et al. Hyperuricemia in patients with coronary artery disease and its association with disease severity[J]. Cureus, 2021, 13(8): e17161. DOI: 10.7759/cureus.17161.

[23] Lv S, Liu W, Zhou Y, et al. Hyperuricemia and severity of coronary artery disease: an observational study in adults 35 years of age and younger with acute coronary syndrome[J]. Cardiol J, 2019, 26(3): 275-282. DOI: 10.5603/CJ.a2018.0022.

[24] Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis[J]. Arthritis Care Res (Hoboken), 2010, 62(2): 170-180. DOI: 10.1002/acr.20065.

[25] Zuo T, Liu X, Jiang L, et al. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies[J]. BMC Cardiovasc Disord, 2016, 16(1): 207. DOI: 10.1186/s12872-016-0379-z.

[26] Spoon DB, Lerman A, Rule AD, et al. The association of serum uric acid levels with outcomes following percutaneous coronary intervention[J]. J Interv Cardiol, 2010, 23(3): 277-283. DOI: 10.1111/j.1540-8183. 2010.00555.x.

[27] Ndrepepa G, Braun S, King L, et al. Association of uric acid with mortality in patients with stable coronary artery disease[J]. Metabolism, 2012, 61(12): 1780-1786. DOI: 10.1016/j.metabol.2012.05.014.

[28] Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study[J]. Ann Intern Med, 1999, 131(1):7-13.DOI:10.7326/0003-4819-131-1- 199907060- 00003.

[29] Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan[J]. Curr Med Res Opin, 2004, 20(3): 369-379. DOI: 10.1185/030079904125002982.

[30] Silbernagel G, Hoffmann MM, Grammer TB, et al. Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography[J]. Nutr Metab Cardiovasc Dis, 2013, 23(1): 46-52. DOI: 10.1016/j.numecd.2011.02.008.

[31] Wang X, Hou Y, Wang X, et al. Relationship between serum uric acid levels and different types of atrial fibrillation: an updated meta-analysis[J]. Nutr Metab Cardiovasc Dis, 2021, 31(10): 2756-2765. DOI: 10.1016/j.numecd.2021. 05.034.

[32] Huang G, Xu RH, Xu JB, et al. l. Hyperuricemia is associated with atrial fibrillation prevalence in very elderly - a community based study in Chengdu, China[J]. Sci Rep, 2018, 8(1): 12403. DOI: 10.1038/s41598-018- 30321-z.

[33] Zhang J, Zheng R, Li H, et al. Serum uric acid and incident atrial fibrillation: a systematic review and dose-response meta-analysis[J]. Clin Exp Pharmacol Physiol, 2020, 47(11): 1774-1782. DOI: 10.1111/1440-1681.13374.

[34] Tamariz L, Agarwal S, Soliman EZ, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study) [J]. Am J Cardiol, 2011, 108(9): 1272-1276. DOI: 10.1016/j.amjcard.2011.06.043.

[35] Taufiq F, Li P, Miake J, et al. Hyperuricemia as a risk factor for atrial fibrillation due to soluble and crystalized uric acid[J]. Circ Rep, 2019, 1(11): 469-473. DOI: 10.1253/circrep.CR-19-0088.

[36] Singh JA, Yu S. Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data[J]. Ann Rheum Dis, 2017, 76(1): 72-78. DOI: 10.1136/annrheumdis- 2015-209008.

[37] Chao TF, Liu CJ, Chen SJ, et al. Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation--could it refine clinical risk stratification in AF?[J]. Int J Cardiol, 2014, 170(3): 344-349. DOI: 10.1016/j.ijcard.2013.11.011.